Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
Covid-19 vaccine makers may find shelter from patent lawsuits under a legal theory Moderna is floating.
Covid-19 vaccine makers may find shelter from patent lawsuits under a legal theory Moderna is floating.
U.S. Supreme Court justices focused on plaintiffs’ right to sue the FDA to reinstate restrictions on a commonly used abortion pill, suggesting they are unlikely…
AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating…
The European Commission has opened an antitrust investigation to determine whether Zoetis, one of the largest purveyors of medicines for dogs and cats, breached EU…
Amgen accused a Colorado board of violating the U.S. Constitution with its first-in-the-nation plan to cap the cost of a pricey prescription medicine.
Amgen filed a lawsuit accusing a Colorado state board of violating the Constitution over a plan to pursue a cap on the cost of a…
Chick-fil-A, one of the largest fast-food restaurants in the U.S., is easing its commitment to using chickens raised without any antibiotics.
Novo Nordisk agreed to acquire Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional cardiometabolic drug candidates.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
This morning in the Pharmalittle roundup: We’re reading about Medicare and obesity drugs, FDA syringe warnings, and more.
The Congressional Budget Office forecast that Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years.”